Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Captopril in primary pulmonary hypertension.

C V Leier, D Bambach, S Nelson

    Circulation
    |January 1, 1983
    PubMed
    Summary

    Captopril significantly reduced systemic blood pressure in women with primary pulmonary hypertension but did not improve pulmonary artery pressure or exercise tolerance. Chronic captopril therapy offered limited benefits for most patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Low-Frequency Self-Powered Footstep Sensor Based on ZnO Nanowires on Paper Substrate.

    Nanoscale research letters·2016
    Same author

    The StarClose Vascular Closure System: interventional results from the CLIP study.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2006
    Same author

    The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2006
    Same author

    Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1--the medical history.

    Congestive heart failure (Greenwich, Conn.)·2002
    Same author

    Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

    Congestive heart failure (Greenwich, Conn.)·2002
    Same author

    Fluoroscopic diagnosis of native valve endocarditis.

    Circulation·2001

    Area of Science:

    • Cardiology
    • Pulmonology
    • Pharmacology

    Background:

    • Primary pulmonary hypertension (PPH) is a severe condition characterized by high blood pressure in the pulmonary arteries.
    • Current treatments for PPH have limited efficacy, necessitating research into alternative therapeutic options.

    Purpose of the Study:

    • To evaluate the hemodynamic effects of captopril, an angiotensin-converting enzyme inhibitor, in women with PPH.
    • To determine if captopril improves exercise tolerance and pulmonary hemodynamics in patients with PPH.

    Main Methods:

    • Seven women with PPH underwent hemodynamic assessments at rest and during exercise.
    • Captopril was administered orally in escalating doses (25, 50, 100 mg) to establish dose-response curves.
    • Four patients received chronic captopril therapy (75-100 mg every 8 hours) for 12 weeks, with repeat hemodynamic evaluations.

    Related Experiment Videos

    Main Results:

    • Captopril significantly reduced systemic blood pressure and systemic vascular resistance, effects sustained during submaximal exercise.
    • No significant changes were observed in pulmonary artery pressure, pulmonary vascular resistance, cardiac output, or stroke volume at rest or during exercise.
    • Chronic captopril administration resulted in a persistent reduction in resting mean systemic blood pressure but did not alter exercise duration or other hemodynamic parameters.

    Conclusions:

    • Captopril primarily affects the systemic vasculature in patients with PPH, with minimal impact on the pulmonary circuit.
    • While some patients may experience subjective improvement, captopril therapy is unlikely to benefit the majority of adult patients with severe PPH.
    • Further research may be needed to identify specific patient subgroups who could benefit from captopril or similar agents in PPH management.